1. FAERS reports April-June 2019

   News item 09 November 2019 Pages: 1 - 1

2. Follow-up Canadian review of liver injury risk with Xarelto

   News item 09 November 2019 Pages: 2 - 2

3. Gentamicin 40 mg/mL ampoules: alternative during shortage

   News item 09 November 2019 Pages: 3 - 3

4. PMDA investigations for vonoprazan, belimumab medicines

   News item 09 November 2019 Pages: 4 - 4

5. FDA introducing electronic submission of IND safety reports

   News item 09 November 2019 Pages: 5 - 5

6. FDA warns of potentially harmful homeopathic products

   News item 09 November 2019 Pages: 6 - 6

7. Amiodarone associated with low AE rate

   Clinical study 09 November 2019 Pages: 7 - 7

8. ASCO's Decision Aid: improved adverse event attribution

   Clinical study 09 November 2019 Pages: 8 - 8

9. Fractures with SGLT-2 vs DPP-4 inhibitors

   Clinical study 09 November 2019 Pages: 9 - 9

10. Hypoglycaemia with tramadol

    Clinical study 09 November 2019 Pages: 10 - 10

11. Opioid-related ADEs after TKA increase hospital costs

    Clinical study 09 November 2019 Pages: 11 - 11

12. Potential interactions between apixaban and OTC drugs

    Clinical study 09 November 2019 Pages: 12 - 12

13. Acetazolamide

    Case report 09 November 2019 Pages: 13 - 13

14. Adalimumab

    Case report 09 November 2019 Pages: 14 - 14

15. Adalimumab/amoxicillin

    Case report 09 November 2019 Pages: 15 - 15

16. Adalimumab/infliximab

    Case report 09 November 2019 Pages: 16 - 16

17. Adenosine

    Case report 09 November 2019 Pages: 17 - 17

18. Afatinib/osimertinib

    Case report 09 November 2019 Pages: 18 - 18

19. Afatinib/rivoceranib

    Case report 09 November 2019 Pages: 19 - 19

20. Alectinib/brigatinib

    Case report 09 November 2019 Pages: 20 - 20

21. Alemtuzumab

    Case report 09 November 2019 Pages: 21 - 21

22. Alendronic acid

    Case report 09 November 2019 Pages: 22 - 22

23. Alitretinoin

    Case report 09 November 2019 Pages: 23 - 23

24. Allopurinol

    Case report 09 November 2019 Pages: 24 - 24

25. Allopurinol/captopril interaction

    Case report 09 November 2019 Pages: 25 - 25

26. Alprazolam abuse and overdose

    Case report 09 November 2019 Pages: 26 - 26

27. Amiodarone

    Case report 09 November 2019 Pages: 27 - 27

28. Amiodarone

    Case report 09 November 2019 Pages: 28 - 28

29. Amiodarone

    Case report 09 November 2019 Pages: 29 - 29

30. Amiodarone

    Case report 09 November 2019 Pages: 30 - 30

31. Amisulpride/haloperidol/loxapine

    Case report 09 November 2019 Pages: 31 - 31

32. Amlodipine overdose

    Case report 09 November 2019 Pages: 32 - 32

33. Amoxicillin

    Case report 09 November 2019 Pages: 33 - 33

34. Amoxicillin

    Case report 09 November 2019 Pages: 34 - 34

35. Amoxicillin/clavulanic-acid

    Case report 09 November 2019 Pages: 35 - 35

36. Amoxicillin/ibrutinib

    Case report 09 November 2019 Pages: 36 - 36

37. Amoxicillin/naproxen

    Case report 09 November 2019 Pages: 37 - 37

38. Amphotericin B/furosemide/vancomycin

    Case report 09 November 2019 Pages: 38 - 38

39. Ampicillin

    Case report 09 November 2019 Pages: 39 - 39

40. Anaplastic lymphoma kinase inhibitors: case report

    Case report 09 November 2019 Pages: 40 - 40

41. Antibacterial/isotretinoin

    Case report 09 November 2019 Pages: 41 - 41

42. Antibacterials/Antiparasitics/dexamethasone

    Case report 09 November 2019 Pages: 42 - 42

43. Antibacterials/corticosteroids

    Case report 09 November 2019 Pages: 43 - 43

44. Antibacterials/methylprednisolone

    Case report 09 November 2019 Pages: 44 - 44

45. Antibacterials/vancomycin

    Case report 09 November 2019 Pages: 45 - 45

46. Antibiotics/pantoprazole

    Case report 09 November 2019 Pages: 46 - 46

47. Antihistamines/epinephrine/glucocorticoids

    Case report 09 November 2019 Pages: 47 - 47

48. Antihypertensives/dexmedetomidine

    Case report 09 November 2019 Pages: 48 - 48

49. Antimicrobials

    Case report 09 November 2019 Pages: 49 - 49

50. Antineoplastics

    Case report 09 November 2019 Pages: 50 - 50